Back to All Events

Global Innovative Contracting Webinar: Latest Trends & Insights - March 2024

The March 2024 edition of Verpora's webinar series exploring the latest trends and policies surrounding Global Innovative Contracting. Providing insight from industry experts with real-world experiences in successfully implementing Global Innovative Contracting and interactive discussion of policy considerations.

This webinar provides an overview of some of the latest examples of innovative contracting in the pharmaceutical industry, and highlights new case studies and pilot projects. Our summaries address emerging trends in Innovative Contracting, policy and legislative updates, and expert perspectives on recent news and events.

This month’s sessions focus on:

UK / EU / Asia Session Register Now

  • Introduction to Innovative Contracting

  • Payer challenges and Innovative Contracting in the neurology market

  • Market update in APAC

  • Roctavian case study in Germany

US / LATAM Session Register Now

  • Introduction to Innovative Contracting

  • Medicare price negotiations and the next wave of IC in USA

  • Market update in LATAM

  • Lyfgenia case study (bluebirdBio) in USA

    The webinar concludes with opportunity for questions from participants about any of the updates and developments presented in the webinar.

 

This webinar is open exclusively to employees of pharmaceutical and medical technology organizations…

  • Market access and pricing professionals

  • Global / Regional / National account directors interested
    in Innovative Contracting

  • Pharmaceutical executives

Register Now
This webinar is free of charge. Places are limited to ensure high-quality interactive discussion. 

 

UK / Europe / Asia Webinar Session

Thursday 7 March 2024
08:30 - 09:00 GMT
09:30 Europe / 16:30 China
/ 17:30 Japan, Korea & Australia

USA Webinar Session

Thursday 7 March 2024
16:30 - 17:00 GMT
11:30 EST / 10:30 CST / 08:30 PST


Representing Verpora

Speaker
Omar Ali
Head of Payers, Verpora

It takes a payer to know a payer’s mind, and Omar’s long experience puts him in an ideal position to unlock critical payer insights. A previous pharmacy & therapeutics payer and adviser to the UK national HTA appraisal body NICE, Omar’s experience encompasses the managed entry of new medicines and health technology appraisals with a deep knowledge of market access, pricing, reimbursement and health economics. For Verpora, Omar manages a global team of experienced pharmacy payers who bring in-depth insights to product value propositions and validation of market access strategy across international launch sequence portfolios. Omar is presently studying for his PhD in Value-Based Contracting.

Omar Ali, Verpora

Speaker
Adam Meads

COO & Head of Research Analytics, Verpora

Adam began his career as a research analyst in banking and finance specializing in behavioural research and decision performance as well as buy-side data solutions. He moved into the life sciences sector as a consultant on health system data intelligence at NHiS Ltd (now part of Wilmington plc) before moving to run his own consultancy White Space Analytics (WSA). Following a merger between WSA and Verpora, Adam now leads Verpora’s initiatives in innovative pricing and VBA contracting strategy. He heads Verpora’s Research & Analytics function. Adam is a certified member of the British Healthcare Business Intelligence Association (BHBIA).

Host
Harry Osborn

Account Director, Verpora

Harry is an associate consultant and experienced account manager, having worked in specialist therapy areas for both AstraZeneca and Sanofi over the past 6+ years. At Verpora, Harry utilises his expertise and knowledge of the pharmaceutical industry to manage client interactions and customer engagement. He also has a background in aviation sciences and is a chartered pilot, granting him a unique insight into human performance factors; how people manage and make decisions in both low and high-stress environments. Harry is a certified member of the British Healthcare Business Intelligence Association (BHBIA) and is ABPI qualified.

Harry Osborne, Verpora

Register Now
This webinar is free of charge. Places are limited to ensure high-quality interactive discussion. 

UK / Europe / Asia Webinar Session

Thursday 7 March 2024
08:30 - 09:00 GMT
09:30 Europe / 16:30 China
/ 17:30 Japan, Korea & Australia

USA Webinar Session

Thursday 7 March 2024
16:30 - 17:00 GMT
11:30 EST / 10:30 CST / 08:30 PST

 
Previous
Previous
17 October

12th EPP Life Sciences Pricing Forum 2023

Next
Next
12 March

Can we afford a cure? Rare disease, orphan drugs and innovative contracting - Omar Ali @ World EPA Congress 2024